Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HES
Hess
HES
|
+$1.28B |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$1.02B |
| 3 |
Bank of America
BAC
|
+$770M |
| 4 |
Gilead Sciences
GILD
|
+$378M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$346M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.78B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$973M |
| 3 |
Walt Disney
DIS
|
+$588M |
| 4 |
Eli Lilly
LLY
|
+$569M |
| 5 |
AT&T
T
|
+$529M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.4% |
| 2 | Healthcare | 3.08% |
| 3 | Financials | 2.41% |
| 4 | Consumer Discretionary | 2.33% |
| 5 | Industrials | 1.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
12101
374Water
SCWO
$44.3M
| $49K | ﹤0.01% |
+3,892
| New | +$50.1K |
|
12102
PUT
Stock Yards Bancorp
SYBT
$2.64B
| $48.9K | ﹤0.01% |
+1,000
| New | +$47.4K |
|
|
STKH
12103
Steakholder Foods
STKH
$2.13M
| $48.9K | ﹤0.01% |
70
-11
| -14% | -$7.88K |
|
12104
CALL
CLPS Inc
CLPS
$25.8M
| $48.9K | ﹤0.01% |
45,700
+25,300
| +124% | +$25.8K |
|
12105
Molina Healthcare
MOH
$11.1B
| $48.9K | ﹤0.01% |
119
-1,031
| -90% | -$399K |
|
12106
PUT
Schwab US Mid-Cap ETF
SCHM
$15.4B
| $48.9K | ﹤0.01% |
1,800
-7,500
| -81% | -$191K |
|
12107
CALL
NN Inc
NNBR
$322M
| $48.8K | ﹤0.01% |
10,300
+7,500
| +268% | +$34.4K |
|
12108
CALL
OmniAb
OABI
$491M
| $48.8K | ﹤0.01% |
9,000
-8,900
| -50% | -$51.3K |
|
12109
PUT
Lloyds Banking Group
LYG
$90.1B
| $48.7K | ﹤0.01% |
18,800
+13,600
| +262% | +$31.2K |
|
12110
CALL
Xencor
XNCR
$1.74B
| $48.7K | ﹤0.01% |
2,200
+400
| +22% | +$8.64K |
|
|
TERN
12111
CALL
DELISTED
Terns Pharmaceuticals
TERN
| $48.5K | ﹤0.01% |
7,400
-8,300
| -53% | -$54.2K |
|
12112
CALL
Vuzix
VUZI
$262M
| $48.5K | ﹤0.01% |
40,100
-55,300
| -58% | -$90.3K |
|
12113
CALL
Humacyte
HUMA
$168M
| $48.5K | ﹤0.01% |
15,600
+14,100
| +940% | +$47.4K |
|
|
AUTL
12114
PUT
Autolus Therapeutics
AUTL
$572M
| $48.5K | ﹤0.01% |
7,600
+4,300
| +130% | +$26.8K |
|
12115
PUT
iShares Micro-Cap ETF
IWC
$1.52B
| $48.5K | ﹤0.01% |
400
-1,700
| -81% | -$195K |
|
12116
POET Technologies
POET
$1.65B
| $48.5K | ﹤0.01% |
35,365
-5,319
| -13% | -$6.59K |
|
|
FINV
12117
FinVolution Group
FINV
$1.03B
| $48.4K | ﹤0.01% |
9,597
-109,516
| -92% | -$539K |
|
12118
PUT
Zegna
ZGN
$3.69B
| $48.3K | ﹤0.01% |
3,300
-8,700
| -73% | -$112K |
|
|
APLT
12119
PUT
DELISTED
Applied Therapeutics
APLT
| $48.3K | ﹤0.01% |
7,100
-6,900
| -49% | -$31K |
|
12120
Ryde Group
RYDE
$157M
| $48.3K | ﹤0.01% |
+13,044
| New | +$64.9K |
|
|
SPNS
12121
PUT
DELISTED
Sapiens International
SPNS
| $48.2K | ﹤0.01% |
1,500
+100
| +7% | +$2.9K |
|
12122
CALL
Pyxis Oncology
PYXS
$251M
| $48.1K | ﹤0.01% |
11,300
+9,200
| +438% | +$38.7K |
|
|
GREK
12123
CALL
Global X MSCI Greece ETF
GREK
$334M
| $48K | ﹤0.01% |
1,200
-1,400
| -54% | -$55.4K |
|
12124
PUT
VSE Corp
VSEC
$6.79B
| $48K | ﹤0.01% |
600
-4,000
| -87% | -$273K |
|
|
AAMI
12125
PUT
Acadian Asset Management
AAMI
$3.28B
| $48K | ﹤0.01% |
2,100
| – | – |
|
Similar funds
Citadel Advisors's Q1 2024 Portfolio in Review
As of Q1 2024, Citadel Advisors held 15,912 positions worth $518B, up 3.6% from $500B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Citadel Advisors withdrew a net $36B in Q1 2024, closing 1,439 positions and reducing 6,148 holdings. Its most notable exit was iShares National Muni Bond ETF, an estimated $183M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.4% of assets, down from 3.8% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Citadel Advisors opened a new position in TD Synnex worth $245M.
- Citadel Advisors's largest Q1 2024 buy was TD Synnex: 2,162,840 shares worth $245M.
- Citadel Advisors added most to Hess in Q1 2024, an estimated $1.28B increase.
- Citadel Advisors's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $1.78B.
- Citadel Advisors fully exited iShares National Muni Bond ETF in Q1 2024, selling an estimated $183M.
- Citadel Advisors's ten largest holdings make up 30% of its $518B portfolio in Q1 2024.
- Citadel Advisors opened 1,749 new positions and closed 1,439 in Q1 2024.
- Citadel Advisors's portfolio value rose 3.6% quarter-over-quarter to $518B.
Based on Citadel Advisors's 13F filing for Q1 2024, filed 15 May 2024.